Nimble Clinical Research, a US-based innovator specializing in AI-powered technology for automating complex clinical trial processes, and CuMinds Innovations, an India-based Knowledge-as-a-Solution (KaaS) provider focused on clinical data science services, today announced a strategic partnership. This collaboration is designed to accelerate the implementation and adoption of Nimble’s advanced AI/ML platform across Contract Research Organizations (CROs) and the broader Pharmaceutical sector, with a particular focus on enhancing Nimble’s reach within the APAC region.
Nimble Clinical Research provides the cutting-edge ‘Nimble’ platform, which leverages artificial intelligence to streamline and enhance critical clinical trial functions including Data Management, Risk-Based Quality Management (RBQM), Biostatistics, Programming, and Analytics. Their solutions feature AI-driven clinical document generation (protocols, CRFs compliant with CDASH/SDTM), accelerated study startup tools including automated risk assessment, AI-enhanced data review for superior quality checks, intuitive data visualization dashboards, and automated generation of submission-ready SDTM/ADaM datasets.
This partnership synergistically combines Nimble’s advanced AI technology with CuMinds Innovations’ deep expertise in technology adoption, implementation services, and specialized clinical data science. CuMinds excels as a KaaS partner, offering tailored insights and solutions for real-world business challenges in Pharma and Healthcare. Their core strengths lie in Risk-Based Data Science, utilizing Quality by Design (QbD) principles for proactive risk identification, assessment, monitoring, and mitigation throughout the clinical trial lifecycle. CuMinds brings extensive experience in implementing risk-based strategies and data review tools, ensuring clients can effectively integrate and maximize the value of new technologies.
The joint effort will specifically target the deployment of Nimble’s AI automation platform to drive significant improvements for clients. By integrating Nimble’s AI capabilities for tasks like automated data quality checks, SDTM generation, and risk identification with CuMinds’ proven methodologies for Risk-Based Data Science implementation and central monitoring strategies, the partnership aims to deliver faster, more robust adoption of data-driven decision-making tools. This collaboration will empower organizations to enhance patient safety through better risk management, improve clinical research quality via superior data integrity, and boost operational efficiency by automating manual processes and accelerating insights.
“We are thrilled to partner with CuMinds Innovations, whose deep domain expertise and proven implementation track record are highly complementary to our AI technology,” said Vineet Jain, CEO of Nimble Clinical Research. “Their strong presence and understanding of the APAC market are invaluable as we seek to expand the reach and impact of our clinical analysis and automation solutions globally, empowering more organizations with efficient, AI-driven trial execution.”
“Nimble Clinical Research offers a truly next-generation AI platform designed to tackle key bottlenecks in clinical trials,” stated Mukesh Babu K, Chief Consulting Officer at CuMinds Innovations. “By combining their innovative technology with our specialized KaaS approach and Risk-Based Data Science expertise, we aim to empower the clinical trial industry with tangible, actionable insights that significantly improve patient outcomes, optimize operational processes, and ensure regulatory readiness.”
Nimble Clinical Research, USA
Nimble Clinical Research is an AI-powered technology provider specializing in the implementation of artificial intelligence across Data Management, Risk-Based Quality Management (RBQM), Biostatistics, Programming, and Analytics
&
CuMinds Innovations, India CuMinds Innovations is your dedicated Knowledge-as-a-Solution (KaaS) partner. We offer a wide range of knowledge and expertise to empower individuals and organizations. We aim to deliver valuable insights tailored to address the unique real-world business challenges within the Pharmaceutical, Healthcare, and Clinical Trial sectors.
Your request has been submitted successfully.
Thanks for contacting us. We will get back as soon as we can!
Nimble Clinical Research, a US-based innovator specializing in AI-powered technology for automating complex clinical trial processes, and CuMinds Innovations, an India-based Knowledge-as-a-Solution (KaaS) provider focused on clinical data science services, today announced a strategic partnership. This collaboration is designed to accelerate the implementation and adoption of Nimble’s advanced AI/ML platform across Contract Research Organizations (CROs) and the broader Pharmaceutical sector, with a particular focus on enhancing Nimble’s reach within the APAC region.
Nimble Clinical Research provides the cutting-edge ‘Nimble’ platform, which leverages artificial intelligence to streamline and enhance critical clinical trial functions including Data Management, Risk-Based Quality Management (RBQM), Biostatistics, Programming, and Analytics. Their solutions feature AI-driven clinical document generation (protocols, CRFs compliant with CDASH/SDTM), accelerated study startup tools including automated risk assessment, AI-enhanced data review for superior quality checks, intuitive data visualization dashboards, and automated generation of submission-ready SDTM/ADaM datasets.
This partnership synergistically combines Nimble’s advanced AI technology with CuMinds Innovations’ deep expertise in technology adoption, implementation services, and specialized clinical data science. CuMinds excels as a KaaS partner, offering tailored insights and solutions for real-world business challenges in Pharma and Healthcare. Their core strengths lie in Risk-Based Data Science, utilizing Quality by Design (QbD) principles for proactive risk identification, assessment, monitoring, and mitigation throughout the clinical trial lifecycle. CuMinds brings extensive experience in implementing risk-based strategies and data review tools, ensuring clients can effectively integrate and maximize the value of new technologies.
The joint effort will specifically target the deployment of Nimble’s AI automation platform to drive significant improvements for clients. By integrating Nimble’s AI capabilities for tasks like automated data quality checks, SDTM generation, and risk identification with CuMinds’ proven methodologies for Risk-Based Data Science implementation and central monitoring strategies, the partnership aims to deliver faster, more robust adoption of data-driven decision-making tools. This collaboration will empower organizations to enhance patient safety through better risk management, improve clinical research quality via superior data integrity, and boost operational efficiency by automating manual processes and accelerating insights.
“We are thrilled to partner with CuMinds Innovations, whose deep domain expertise and proven implementation track record are highly complementary to our AI technology,” said Vineet Jain, CEO of Nimble Clinical Research. “Their strong presence and understanding of the APAC market are invaluable as we seek to expand the reach and impact of our clinical analysis and automation solutions globally, empowering more organizations with efficient, AI-driven trial execution.”
“Nimble Clinical Research offers a truly next-generation AI platform designed to tackle key bottlenecks in clinical trials,” stated Mukesh Babu K, Chief Consulting Officer at CuMinds Innovations. “By combining their innovative technology with our specialized KaaS approach and Risk-Based Data Science expertise, we aim to empower the clinical trial industry with tangible, actionable insights that significantly improve patient outcomes, optimize operational processes, and ensure regulatory readiness.”
Nimble Clinical Research, USA
Nimble Clinical Research is an AI-powered technology provider specializing in the implementation of artificial intelligence across Data Management, Risk-Based Quality Management (RBQM), Biostatistics, Programming, and Analytics
&
CuMinds Innovations, India
CuMinds Innovations is your dedicated Knowledge-as-a-Solution (KaaS) partner. We offer a wide range of knowledge and expertise to empower individuals and organizations. We aim to deliver valuable insights tailored to address the unique real-world business challenges within the Pharmaceutical, Healthcare, and Clinical Trial sectors.